Antiretroviral Adherence and Drug-level Monitoring

Launched by ZAMROTUL IZZAH · Aug 10, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how well people with HIV in Indonesia are sticking to their medication plans, specifically those using a type of medicine called tenofovir. The study will also check the levels of the medication in their bodies to see if they're getting the right amount. It's important because taking medication as prescribed can help manage HIV and improve health.

To join the study, participants must be adults who have been on tenofovir-based treatment for at least six months. However, pregnant or breastfeeding women, individuals with serious kidney problems, or those with uncontrolled health issues like diabetes or high blood pressure cannot participate. If eligible and willing to join, participants can expect to be monitored regularly and contribute valuable information to help improve HIV treatment in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults with HIV who have been receiving antiretroviral therapy containing tenofovir-based regimens for at least six months
• Exclusion Criteria:
• • Pregnant and breastfeeding women, people with kidney failure, undergoing hemodialysis or peritoneal dialysis, uncontrolled diabetes, uncontrolled hypertension, and hypersensitivity to tenofovir